Sexually transmitted infection services as a component of HIV care: Findings of a demonstration project among HIV-infected women in Thailand

Journal of Acquired Immune Deficiency Syndromes

Volumn 41, Issue 5, 2006, Pages 671-674

  Sirivongrangson, Pachara ^a   Bollen, Liesbeth J M ^a,c   Chaovavanich, Achara ^b   Suksripanich, Orapin ^c   Jirarojwat, Naiyana ^a   Virapat, Pongsri ^c   Charoenwatanachokchai, Angkana ^a   Lokpichat, Somchai ^a   Pobkeeree, Vallerut ^c   Chantharojwong, Nartlada ^c   Supawitkul, Somsak ^c   Tappero, Jordan W ^a,c   Levine, William C ^a,c  

^a MINISTRY OF PUBLIC HEALTH   (Thailand)

^b Bamrasnaradura Infectious Disease Institute   (Thailand)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

HIV infection; Prevention; Sexually transmitted infections; Thailand

Indexed keywords

ADULT; CHLAMYDIA INFECTIONS; FEMALE; GONORRHEA; HIV INFECTIONS; HUMANS; PROSTITUTION; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; THAILAND;

EID: 33646814766     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000194233.92959.be     Document Type: Article

References (13)

1. Boiley MC, Bastos F, Desai K, et al. Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis. 2004;31:100-113.
2. Hosseinipour M, Cohen MS, Vernazza PL, et al. Can antiretroviral therapy be used to prevent sexual transmission of human immunodeficiency virus type 1? Clin Infect Dis. 2002;34:1391-1395.
3. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV: recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Morb Mortal Wkly Rep. 2003;52(RR-12):1-24.
4. Global HIV Prevention Working Group. HIV prevention in the era of expanded treatment. 2004. Available at: http://www.kff.org/hivaids/ hiv061004pkg.cfm. Accessed October 4, 2005.
5. Valdiserri RO. International scale-up for antiretroviral treatment: where does prevention fit? J Acquir Immune Defic Syndr. 2004;37(Suppl):S138-S141.
6. Røttingen JA, Cameron DW, Garnett GP. A systematic review of the epidemiologic interactions between classic sexually transmitted diseases and HIV: how much is really known? Sex Transm Dis. 2001;28:579-597.
7. Rothenberg RB, Wasserheit JN, St Louis M, et al. The effect of treating sexually transmitted diseases on the transmission of HIV in dually infected persons: a clinic-based estimate. Sex Transm Dis. 2000;27:411-416.
8. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. MMWR Morb Mortal Wkly Rep. 2002;51(RR-6):10.
9. Bureau of AIDS, TB and STIs, Thai Ministry of Public Health. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. 8th ed. ISBN 974-297-298-2. Bangkok, Thailand.
10. Beyrer C, Jitwatcharanan K, Natpratan C, et al. Molecular methods for the diagnosis of genital ulcer disease in a sexually transmitted disease clinic population in Northern Thailand: predominance of herpes simplex virus infection. J Infect Dis. 1998;178:243-246.
11. Celum CL, Robinson NJ, Cohen MS. Potential effect of HIV type 1 antiretroviral and herpes simplex virus type 2 antiviral therapy on transmission and acquisition of HIV type 1 infection. J Infect Dis. 2005;191(Suppl):S107- S114.
12. Scheer S, Lee Chu P, Klausner JD, et al. Effect of highly active antiretroviral therapy on diagnoses of sexually transmitted diseases in people with AIDS. Lancet. 2001;357:432-435.
13. Diamond C, Richardson JL, Milam J, et al. Use of and adherence to antiretroviral therapy is associated with decreased sexual risk behavior in HIV clinic patients. J Acquir Immune Defic Syndr. 2005;39:211-218.